[{"id":"22ffb21f-989e-4653-87ef-38c78fadff5f","acronym":"","url":"https://clinicaltrials.gov/study/NCT03054298","created_at":"2021-01-18T15:02:34.204Z","updated_at":"2024-07-02T16:35:22.364Z","phase":"Phase 1","brief_title":"CAR T Cells in Mesothelin Expressing Cancers","source_id_and_acronym":"NCT03054298","lead_sponsor":"University of Pennsylvania","biomarkers":" PD-L1","pipe":" | ","alterations":" MSLN expression","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSLN expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • TmMSTN-01"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 65","initiation":"Initiation: 04/06/2017","start_date":" 04/06/2017","primary_txt":" Primary completion: 03/01/2025","primary_completion_date":" 03/01/2025","study_txt":" Completion: 03/01/2025","study_completion_date":" 03/01/2025","last_update_posted":"2024-01-24"}]